IRIS
BAROCELLI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.486
EU - Europa 8.901
AS - Asia 4.734
AF - Africa 157
SA - Sud America 39
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 4
Totale 24.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.252
CN - Cina 2.856
FI - Finlandia 1.890
SE - Svezia 1.717
IE - Irlanda 1.645
SG - Singapore 1.237
IT - Italia 1.079
UA - Ucraina 942
DE - Germania 870
TR - Turchia 421
GB - Regno Unito 232
CA - Canada 209
IN - India 132
BE - Belgio 118
CI - Costa d'Avorio 118
FR - Francia 106
AT - Austria 75
RO - Romania 58
CZ - Repubblica Ceca 51
EU - Europa 32
CM - Camerun 26
BR - Brasile 22
VN - Vietnam 21
NL - Olanda 19
ES - Italia 16
RU - Federazione Russa 15
PA - Panama 14
HK - Hong Kong 12
LT - Lituania 12
KR - Corea 11
IR - Iran 9
JP - Giappone 9
TW - Taiwan 8
PL - Polonia 7
HU - Ungheria 6
MX - Messico 6
SC - Seychelles 6
AR - Argentina 5
CH - Svizzera 5
CL - Cile 5
SI - Slovenia 5
BG - Bulgaria 4
DK - Danimarca 4
HR - Croazia 4
PK - Pakistan 4
AU - Australia 3
EC - Ecuador 3
LU - Lussemburgo 3
MD - Moldavia 3
PH - Filippine 3
PT - Portogallo 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
IL - Israele 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
MA - Marocco 1
MC - Monaco 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 24.354
Salva come PNG Salva come JPEG
Città #
Chandler 1.661
Dublin 1.644
Jacksonville 1.109
Singapore 983
Santa Clara 971
Ann Arbor 894
Dearborn 768
Beijing 583
Ashburn 477
Boardman 472
Nanjing 422
Izmir 394
Parma 394
Princeton 310
Shanghai 294
New York 233
Wilmington 212
San Mateo 210
Toronto 160
Bremen 151
Helsinki 145
Hebei 133
Kunming 132
Nanchang 132
Shenyang 123
Jinan 121
Abidjan 118
Brussels 114
Hefei 100
Des Moines 91
Grafing 84
Woodbridge 82
Guangzhou 74
Vienna 72
Los Angeles 70
Tianjin 63
Jiaxing 62
Changsha 59
Seattle 59
Fremont 53
Munich 41
Norwalk 40
Hangzhou 36
Chicago 34
Auburn Hills 33
Houston 31
Zhengzhou 31
Brno 30
Marseille 29
Pune 28
Bangalore 27
Bologna 27
West Jordan 27
Dallas 26
Ottawa 26
Milan 25
Haikou 24
Kocaeli 23
London 22
Düsseldorf 20
Fuzhou 20
Redmond 19
Lanzhou 18
Modena 18
Taizhou 18
Brescia 17
Frankfurt am Main 17
Hyderabad 17
Taiyuan 17
Chengdu 16
Mestre 16
Ningbo 16
Timisoara 16
Falls Church 15
Redwood City 15
Dong Ket 14
Montegaldella 13
Rome 13
Carpi 12
Montréal 12
Borås 11
Madrid 11
Pesaro 11
Tulsa 10
Chongqing 9
Lubbock 9
Mordano 9
Palermo 9
Leipzig 8
Naples 8
Nuremberg 8
Belo Horizonte 7
Focsani 7
Hanoi 7
Kraków 7
Prague 7
Quzhou 7
Shaoxing 7
Wenzhou 7
Amsterdam 6
Totale 15.293
Salva come PNG Salva come JPEG
Nome #
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 252
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 207
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 201
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 198
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 167
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 165
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 157
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 156
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 150
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 140
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 133
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 128
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 126
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 124
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 122
2-Aminobenzimidazoles as new potent H3-antagonists 122
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 120
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 117
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 117
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 115
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 115
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 114
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 112
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 111
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 111
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 111
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 110
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 110
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 110
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 107
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 107
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 106
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 106
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 106
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 106
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 105
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 102
Inflammatory proteases released in a mouse model of intestinal ischemia 101
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 101
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 100
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 100
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 100
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 99
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 99
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 99
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 99
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 99
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 98
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 98
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 97
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 97
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 97
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 97
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 97
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 97
Aminobenzimidazoles as new potent H3-antagonists 97
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 97
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 97
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 96
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 96
R-a-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors 96
Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine 95
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 94
Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites 94
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells 94
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 93
Hake fish bone as a calcium source for efficient bone mineralization 93
Motor responses of rat hypertrophic intestine following chronic obstruction 93
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 93
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 92
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 92
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 92
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 91
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 90
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 90
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 90
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 90
Bitter taste receptors (T2Rs) expression and regulation in the gastrointestinal tract in mice. 89
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 89
Discovery of natural extracts interfering with EphA2-ephrinA1 system 89
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 89
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 89
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 88
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 88
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 88
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 87
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 87
Analgesic activity of new hybrid muscarinic agonists in mice 87
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 86
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 86
Eph-ephrin antagonism in tumor angiogenesis and growth: UniPR1331 preclinical evidence. 86
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 85
CNS access of selected H3-antagonists: ex vivo binding study in rats 85
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 85
Farmaci Lassativi e Farmaci Antidiarroici 85
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 85
Plasma concentration and brain penetration of the H3-receptor antagonist Thioperamide in rats 84
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 84
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 84
Novel antiplatelet and antithrombotic activities of essential oil from Lavandula hybrida Reverchon "Grosso" 83
Totale 10.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.438 0 0 0 0 0 573 587 105 454 292 160 267
2020/20212.297 44 265 205 72 305 109 279 50 458 96 336 78
2021/20221.869 64 57 53 239 117 126 199 213 71 125 116 489
2022/20236.474 760 675 390 473 646 725 111 361 1.997 57 199 80
2023/20242.213 128 194 59 88 168 565 211 119 85 111 160 325
2024/20253.138 229 397 514 411 723 864 0 0 0 0 0 0
Totale 24.663